(Q54570680)

1 June 2018

title

Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy. (English)

1 reference

1 June 2018

1 reference

2

Toyomasa Katagiri

1 reference

1 June 2018

author name string

Ryo Takata

1

1 reference

1 June 2018

Mitsugu Kanehira

3

1 reference

1 June 2018

Taro Shuin

4

1 reference

1 June 2018

Tsuneharu Miki

5

1 reference

1 June 2018

Mikio Namiki

6

1 reference

1 June 2018

Kenjiro Kohri

7

1 reference

1 June 2018

Tatsuhiko Tsunoda

8

1 reference

1 June 2018

Tomoaki Fujioka

9

1 reference

1 June 2018

Yusuke Nakamura

10

1 reference

1 June 2018

publication date

1 January 2007

1 reference

1 June 2018

published in

Cancer Science

1 reference

1 June 2018

volume

98

1 reference

1 June 2018

page(s)

113-117

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00366.X

Update on chemotherapy for advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00366.X

Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00366.X

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00366.X

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00366.X

10.1111/J.1349-7006.2006.00366.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

17116130

1 reference

1 June 2018